The cultured meat spinout of Maastricht University raised $8.7m to help scale the manufacturing of meat products grown from stem cells.

Mosa Meat, a Netherlands-based cultured meat developer spun out from Maastricht University, obtained €7.5m ($8.7m) on Tuesday in a series A round co-led by meat processing group Bell Food and pharmaceutical firm Merck.

GlassWall Syndicate also participated in the round. Merck took part through its corporate venturing subsidiary, M Ventures.

Founded in 2016, Mosa Meat is developing a commercial production process to generate synthetic meat grown from cultured animal organisms such as cells rather than by slaughtering livestock.

The approach…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?